PATENT CLAIM ANALYSIS

Application Number: 16003855
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "449000"]

Abstract:
The invention relates to a transdermal therapeutic system for administering the active substance buprenorphine. Said system comprises at least one carboxylic acid that determines the solubility of buprenorphine in the matrix layer and that can likewise be absorbed. The transdermal therapeutic system according to the invention is used in the treatment of pain and characterized by a considerably increased utilization of the active substance.

Claim (Index 18):
The transdermal therapeutic system according to  claim 1 , wherein the droplets in the matrix layer consist essentially of the buprenorphine and the at least one carboxylic acid.

Metadata:
- Claim Count in Document: 75.0
- Percentile: 94.0
- Lexical Diversity: 1.52273
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12515848', '14992122', '13885958', '12301244', '14893020']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7272760665702138
- 35 USC 102 Novelty (BERT): 0.5521356407555461
- Combined Prediction Score: 0.709762023988747
- Mean Citation Score: 239.250206
- Max Citation Score: 412.56885
- Similarity Product: 343.9648968755096

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test